Stock IBP INDO-BANGLA PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Indo-Bangla Pharmaceuticals Limited

Equities

IBP

BD0494IBPL08

End-of-day quote Dhaka S.E.
Other stock markets
 03:30:00 30/06/2024 am IST 		5-day change 1st Jan Change
13.3 BDT -2.21% Intraday chart for Indo-Bangla Pharmaceuticals Limited -1.48% -29.63%
13/05 Indo-Bangla Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 CI
11/02 Indo-Bangla Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Indo-Bangla Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024
CI
Indo-Bangla Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023
CI
Indo-Bangla Pharmaceuticals Limited Recommends No Dividend for the Year Ended June 30, 2023
CI
Indo-Bangla Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended September 30, 2023
CI
Indo-Bangla Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023
CI
Indo-Bangla Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023
CI
Indo-Bangla Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022
CI
Indo-Bangla Pharmaceuticals Limited Announces Purchase of Land
CI
Indo-Bangla Pharmaceuticals Limited Recommends Cash Dividend for the Year Ended on June 30, 2021
CI
Indo-Bangla Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended September 30, 2020
CI
47,669,000 Ordinary Shares of Indo-Bangla Pharmaceuticals Limited are subject to a Lock-Up Agreement Ending on 1-OCT-2020.
CI
Indo-Bangla Pharmaceuticals Limited Announces Address Change of Corporate Office
CI
Indo-Bangla Pharmaceuticals Limited Announces Manufacturing Agreement with Rhk Global (Hk) Ltd
CI
Indo-Bangla Pharmaceuticals Limited Reports Earnings Results for the Third Quarter Ended March 31, 2019
CI
Indo-Bangla Pharmaceuticals Limited Reports Earnings Results for the Second Quarter Ended December 31, 2018
CI
Indo-Bangla Pharmaceuticals Limited Reports Earnings Results for the Year Ended June 30, 2018
CI
Indo-Bangla Pharmaceuticals Limited Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended on September 30, 2018
CI
25,331,000 Ordinary Shares of Indo-Bangla Pharmaceuticals Limited are subject to a Lock-Up Agreement Ending on 1-OCT-2018.
CI
Indo-Bangla Pharmaceuticals Limited has completed an IPO in the amount of BDT 200 million.
CI
Indo-Bangla Pharmaceuticals Limited has filed an IPO in the amount of BDT 200 million.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IBP Stock
  4. News Indo-Bangla Pharmaceuticals Limited